AdaptHealth Corp.

NASDAQ:AHCO

Medical - Devices

Healthcare
$7.37 +0.10%

+$0.01 today

Market cap
$1.01B
Beta
1.46
P/E (TTM)
-16.3
EPS (TTM)
-$0.59
52W Low $8.06High $13.43

Volume 1.54M

Average 1.38M

AHCO Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

AdaptHealth Corp.NASDAQ: AHCO

Gross Margin · Q1 FY2026 · quarter ended Apr 2026

Gross margin widens to 12.4%

Gross margin was 12.4% in Q1 FY2026, up 25.6 pp from a year earlier. On a trailing-twelve-month basis it was 5.4%, up 0.6 pp year over year. Over 3 fiscal years it widened by 3.5 pp.

Context

  • Gross margin widened in 1 of the last 3 fiscal years.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterApr 2026
12.4%-6.8 pp QoQ
Last fiscal yearDec 2025
17.5%-3.4 pp YoY
LTMApr 2026
5.4%+0.6 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+25.6 pp——
1 year-3.4 pp——
3 years+3.5 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
17.5%
Year-over-year change
-3.4pp

Gross Margin vs competitors

How AHCO compares with its peers on the latest reported figures

  • AHCO's LTM Apr 2026 gross margin of 5.4% is the lowest of the 9 companies compared; the peer median is 57.2%.
  • Its year-over-year change of +0.6 pp is the 8th highest of 9, against a peer median of +2.2 pp.
  • Over three fiscal years its change of +3.5 pp compares with a peer median of +1.2 pp.
AHCO Competitors Peer median
Gross Margin for AHCO and competitors
Company Period LTM level YoY 3-year change
INSPInspire Medical Systems, Inc.LTM Jun 202686.1% +1.7 pp+1.6 pp
ELMDElectromed, Inc.LTM Mar 202678.4% +0.9 pp+2.6 pp
RMDResMed Inc.LTM Jun 202661.2% +1.8 pp+5.3 pp
VMDViemed Healthcare, Inc.LTM Mar 202657.3% -1.4 pp-3.5 pp
BBNXBeta Bionics, Inc.LTM Mar 202657.2% +3.2 pp-44.6 pp
INFUInfuSystem Holdings, Inc.LTM Mar 202656.7% +3.6 pp+0.9 pp
TNDMTandem Diabetes Care, Inc.LTM Mar 202654.9% +8.4 pp+0.8 pp
INGNInogen, Inc.LTM Mar 202648.7% +2.6 pp+6.9 pp
AHCOAdaptHealth Corp.LTM Apr 20265.4% +0.6 pp+3.5 pp
Peer median (excluding AHCO) 57.2%+2.2 pp+1.2 pp

Competitors are the stored peer set for AHCO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2.45B2.97B3.2B3.26B3.24B
Cost of Revenue2.01B2.55B2.52B2.58B2.68B
Gross Profit445.61M417.43M681.77M681.09M568.56M
Gross Margin18.2%14.1%21.3%20.9%17.5%
Research & Development00000
Selling, General & Admin167.51M162.13M190.09M359.24M382.29M
Operating Expenses220.01M227.02M1.28B417.36M382.29M
Depreciation & Amortization258.05M423.44M420.59M365.33M413.04M
EBITDA544.21M630.76M(171.09M)628.02M503.64M
EBITDA Margin22.2%21.2%-5.3%19.3%15.5%
Operating Income225.61M190.41M(598.4M)263.73M186.27M
Operating Margin9.2%6.4%-18.7%8.1%5.7%
Interest Income00000
Interest Expense95.2M109.41M130.3M126.67M105.75M
Other Income / Expenses(34.65M)(92.51M)(125.38M)(127.71M)(201.42M)
Income Before Tax190.96M97.9M(723.78M)136.02M(15.15M)
Pre-Tax Margin7.8%3.3%-22.6%4.2%-0.5%
Income Tax Expense32.81M24.77M(49M)41.24M50.88M
Net Income156.18M69.32M(678.9M)90.42M(70.79M)
Net Margin6.4%2.3%-21.2%2.8%-2.2%
EPS (Basic)1.120.52(5.32)0.62(0.52)
EPS (Diluted)0.670.50(5.31)0.61(0.52)
Weighted Avg Shares126.31M134.18M134.16M133.76M135.15M
Weighted Avg Shares (Diluted)133.03M138.99M134.42M135.53M135.15M

AdaptHealth Corp.

NASDAQ:AHCO

Intrinsic Alpha fair value

Locked

Current Price

$7.37

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.